ACRIVON THERAPEUTICS INC. - COMMON STOCK
8,4600
09-мая-24 14:55:41
15 мин. задержка
Акции
+0,2300
+2,79%
Сегодняшний диапазон
8,0043 - 8,7400
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
24 апр 2024 16:01:00 Источник Nasdaq GlobeNewswire
-
10 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces $130 Million Private Placement Financing
09 апр 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
28 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
04 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
27 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
08 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
06 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 янв 2024 16:00:24 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 янв 2024 08:00:01 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics Appoints Jean-Marie Cuillerot, M.D., as Chief Medical Officer
03 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics to Present at the Piper Sandler Annual Healthcare Conference
21 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
21 ноя 2023 08:00:00 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics Reports Third Quarter 2023 Financial Results and Business Highlights
09 ноя 2023 08:01:00 Источник Nasdaq GlobeNewswire
-
Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
28 сен 2023 16:05:00 Источник Nasdaq GlobeNewswire
-
19 сен 2023 16:32:13 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >